Suppl Text and Figures from Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082)
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)